New test tells you how many T cells for COVID-19 you have

It takes less than 24 hours and could help guide you through the pandemic.

A blood test that measures a key indicator of COVID-19 immunity could help you determine your risk of contracting the coronavirus and whether to get a booster shot.

The challenge: Since the start of the pandemic, individuals have had to constantly weigh the risk of contracting the coronavirus against the benefits of doing, well, practically anything: eating out, grocery shopping, going to the dentist, flying on an airplane

Getting vaccinated lowers the risk (at least temporarily), as does contracting COVID-19 and recovering. But determining just how protected you are at any given time is still largely a guessing game, as antibody tests alone can’t determine COVID-19 immunity.

Why it matters: This uncertainty can add stress to daily life, potentially leading some people to get sick because they underestimated their risk — while others overestimate their risk and miss out on important events.

It also makes it hard to know when to get a booster shot. 

“Monitoring both [antibodies and T cells] will give us a much clearer picture [of immunity].”

Ernesto Guccione

The test: Researchers at Mount Sinai and Duke-NUS Medical School have now developed a blood test that looks at T cells instead of antibodies as an indicator of COVID-19 immunity.

After a patient’s blood sample is collected, it’s mixed with an assay containing bits of coronavirus proteins. If there are any T cells specific to the virus in the sample, this will activate them. Measuring that activation can help determine a patient’s COVID-19 immunity.

“Monitoring both [antibodies and T cells] will give us a much clearer picture [of immunity] and will hopefully inform our re-vaccination strategies,” study co-author Ernesto Guccione told TIME.

An upgrade: This isn’t the first test to look at T cells for COVID-19 immunity — the FDA approved a test called T-Detect for emergency use in March 2021 — but this new test has several advantages.

Most importantly, T-Detect only gives you a yes/no answer about whether you have T cells that react to COVID-19. But the new test can tell you the level of T cell immunity — which is potentially an indicator of how protected you are.

“That’s the hope: by using this test, we can finally get those numbers that were totally unavailable with the previous technology.”

Ernesto Guccione

There are practical benefits, too: while T-Detect takes 7-10 days for results, the new blood test can be done in as little as 24 hours. It’s less work to run and costs about $50 compared to T-Detect’s $150 (though the final price may be marked up by labs).

These upgrades could make it easier to understand what’s going on with COVID-19 immunity in the whole population — how many people are immune, how long does protection last, who needs a booster and when.

“With large numbers comes clarity,” Guccione said. “That’s the hope: by using this test, we can finally get those numbers that were totally unavailable with the previous technology.”

The bottom line: The new blood test is already cleared for use in Europe, but the FDA hasn’t yet authorized its use in the US. 

“To look at the degree of intensity of T cell immunity and have that correlated with protection — we’re not at that level yet.”

Jordi Ochando

When it is authorized, it’ll be able to measure your T cell response to COVID-19, which could help you assess your infection risk, but don’t expect it to tell you exactly how protected you are against the coronavirus — at least not initially.

“To look at the degree of intensity of T cell immunity and have that correlated with protection — we’re not at that level yet,” study co-author Jordi Ochando told NBC News. “But we hope to be at some point.”

So we’ll need to wait to know precisely how to interpret the results of the test. But one benefit of a cheap, fast T cell test is that scientists could finally get enough data to understand how T cells correlate with immunity from infection or serious illness.

We’d love to hear from you! If you have a comment about this article or if you have a tip for a future Freethink story, please email us at tips@freethink.com.

Related
How intestinal viruses could help you live to be 100
People who live past age 100 have a greater diversity of bacteriophages (that is, viruses that infect bacteria) in their intestines.
Cheap drug appears to cut long COVID risk by 41% in small study
The diabetes drug metformin cut COVID-19 patients’ risk of later developing long COVID by 41% in a small study.
Gain-of-function research is more than just tweaking risky viruses
Gain-of-function experiments in the lab can help researchers get ahead of viruses naturally gaining the ability to infect people in the wild.
Something found in bats could help us survive infections and inflammation
This protein may help bats survive viral infections and could be the springboard for new anti-inflammatory drugs.
World’s first vaccine for RSV approved in the US
The FDA has approved the world’s first vaccine for RSV, a potentially deadly viral infection that has long eluded vaccination.
Up Next
Subscribe to Freethink for more great stories